Cyclic patterns of incidence rate for skin malignant melanoma: association with heliogeophysical activityBorislav D Dimitrov
BORDANI, Alzano Lombardo BG 24022, Italy
J Zhejiang Univ Sci B 9:489-95. 2008
..e., out of phase. We summarized and explored more deeply these cyclic variations and discussed their possible associations with heliogeophysical activity (HGA) components exhibiting similar cyclicity...
- Brain metastases of melanoma--mechanisms of attack on their defence system by engineered stem cells in the microenvironment
Borislav D Dimitrov
BORDANI, Alzano Lombardo, Bergamo 24022, Italy
J Zhejiang Univ Sci B 8:609-11. 2007
....
Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamicsPenka A Atanassova
Department of Neurology, Medical University, Plovdiv, Bulgaria
Cerebrovasc Dis 25:225-33. 2008
..Estimates of relative risk and cumulative long-term occurrence of MVE may provide better information and contribute to the optimization of treatment decisions...
Modelling of increased homocysteine in ischaemic stroke: post-hoc cross-sectional matched case-control analysis in young patientsPenka A Atanassova
Department of Neurology, Medical University 15A, V Aprilov Boulevard, Plovdiv 4000, Bulgaria
Arq Neuropsiquiatr 65:24-31. 2007
..We evaluated relationships between THCY and prevalence of other potential risk factors in 41 patients vs. 41 healthy controls...
- Long-term outcome of renal transplantation from older donors
Giuseppe Remuzzi
Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy
N Engl J Med 354:343-52. 2006
..This approach may help to expand the donor-organ pool for kidney transplantation...
- Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results
Giuseppe Remuzzi
Clinical Research Center for Rare Diseases Aldo e Cele Dacc, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy
J Am Soc Nephrol 15:3117-25. 2004
..Angiotensin II antagonism is a suitable and well-tolerated treatment for individuals with type 2 diabetes even with GFR levels approaching renal replacement therapy...
- Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes
Aneliya Parvanova
Mario Negri Institute for Pharmacological Research, Negri Bergamo Laboratories, Via Gavazzeni 11, 24125 Bergamo, Italy
J Clin Endocrinol Metab 89:4371-6. 2004
..Longitudinal studies are needed to evaluate the role of IR in the pathogenesis of proliferative retinopathy...
- Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial
Giuseppe Remuzzi
Clinical Research Centre for Rare Diseases, Aldo e Cele Dacc, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica, Bergamo, Italy
Lancet 364:503-12. 2004
..Standard immunosuppression regimens for transplantation should perhaps include azathioprine rather than mycophenolate mofetil, at least for kidney grafts...
- In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial
Norberto Perico
Department of Medicine and Transplantation, Azienda Ospedaliera, Ospedali Riuniti di Bergamo-Mario Negri Institute for Pharmacological Research, Bergamo, Italy
Kidney Int 65:1084-90. 2004
....
- Chronic nephropathies: individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model
Borislav D Dimitrov
Clinical Research Center for Rare Diseases Aldo e Cele Dacc, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica, Bergamo, Italy
Nephron Clin Pract 95:c47-59. 2003
..This may help in optimizing care and costs in nephrology and other medical areas and designing trials in high-risk patients...
- Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual level
Borislav D Dimitrov
Department of Renal Medicine, Clinical Research Centre for Rare Diseases Aldo e Cele Dacco, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica BG, Italy
Kidney Int 63:1924-33. 2003
..Predicting outcomes such as end-stage renal disease (ESRD) by integration and better utilization at individual level of epidemiologic data may facilitate clinical decision-making processes...
- Hyperhomocysteinemia and increased risk of retinopathy: a cross-sectional, case-control study in patients with type 2 diabetes
Aneliya Parvanova
Clinical Research Center for Rare Diseases Aldo e Cele Dacc, Mario Negri Institute for Pharmacological Research, Bergamo, Italy
Diabetes Care 25:2361. 2002
- More concern about transfusion requirement when evaluating quality of life in anemic patients
Esther N Oliva
J Clin Oncol 20:3182-3; author reply 3183-4. 2002
